Δεκ272013Βιβλιογραφικά δεδομέναOff-Therapy Durability of Response to Entecavir Therapy in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Κατηγορία Βιβλιογραφικά δεδομένα27 Δεκεμβρίου 2013 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Incidence of Colorectal Cancer After Liver Transplantation for Primary Sclerosing Cholangitis: A Systematic Review and Meta-AnalysisΕπόμενοNext post:Conversions from Prograf to Advagraf in Adolescents with stable liver transplantsΣχετικά ΆρθραLiver transplantation is the major determinant of > 10-year survival in patients with hepatocellular carcinoma14 Μαΐου 2026Geographic disparities in hepatitis B vaccine coverage across Africa: Implications for targeted interventions and 2030 goals8 Μαΐου 2026Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis6 Μαΐου 2026Risk of de novo HCC in patients with MASLD following direct-acting antiviral – induced cure of HCV infection24 Απριλίου 2026Prognostic significance of mild ascites in patients with cirrhosis14 Απριλίου 2026The Rise of Transplant Oncology in Primary Liver Cancer and Metastatic Disease10 Μαρτίου 2026
Liver transplantation is the major determinant of > 10-year survival in patients with hepatocellular carcinoma14 Μαΐου 2026
Geographic disparities in hepatitis B vaccine coverage across Africa: Implications for targeted interventions and 2030 goals8 Μαΐου 2026
Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis6 Μαΐου 2026
Risk of de novo HCC in patients with MASLD following direct-acting antiviral – induced cure of HCV infection24 Απριλίου 2026
